{"id":"W2546395468","doi":"","title":"Role of Chromogranin A and Neuron-Specific Enolase Biomarkers in Progression-Free Survival (PFS) with Everolimus (EVE) versus Placebo (PB) in Patients with Advanced Pancreatic Neuroendocrine Tumors (pNET) : Phase III RADIANT-3 Results","year":2011,"lang":"en","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chromogranin A; Enolase; Pancreatic neuroendocrine tumor; Neuroendocrine tumors; Placebo; Everolimus; Medicine; Internal medicine; Synaptophysin; Progression-free survival; Immunohistochemistry; Endocrinology; Oncology; Overall survival; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002058513,0.0007716424,0.001876853,0.0003092649,0.0002205832,0.0007989705,0.0005156951,0.0007785162,0.001370304],"category_scores_gemma":[0.001313636,0.0003010228,0.001709702,0.0003504388,0.0005791622,0.001115793,0.0002686821,0.001967354,0.0001957529],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005732346,"about_ca_system_score_gemma":0.0005980386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006828604,"about_ca_topic_score_gemma":0.001707014,"domain_scores_codex":[0.9994895,0.0002612148,0.00004182527,0.00008520621,0.00005740591,0.00006480076],"domain_scores_gemma":[0.9991481,0.0003597469,0.0001876913,0.00007668744,0.0000482004,0.000179426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8398565,0.007178563,0.01644561,0.0003945278,0.002701539,0.00004407481,0.0001277316,0.002176486,0.01507953,0.000135707,0.0006287592,0.1152309],"study_design_scores_gemma":[0.2451536,0.5869218,0.1331196,0.0001140951,0.009048717,0.0003639287,0.0002123751,0.003413745,0.01729677,0.000541112,0.003731468,0.00008283491],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929152,0.005688994,0.0001406538,0.0002371148,0.00007122716,0.00008761424,0.0002699077,0.00002168402,0.0005675034],"genre_scores_gemma":[0.9966011,0.001695284,0.000378873,0.0001647266,0.00008420263,0.0000870266,0.0004170778,0.00001021226,0.0005613377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002058513,"threshold_uncertainty_score":0.01088655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01693685893039755,"score_gpt":0.2663606831153702,"score_spread":0.2494238241849727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}